Showing results (31-40 of 159) with videos related to
Sort By:
Pageof 16
Seminars in Cutaneous Medicine and Surgery|September 15, 2018
IL-23 inhibitors for moderate-to-severe psoriasisErin Ibler, Kenneth B GordonCurrent Directions in Autoimmunity|May 8, 2008
Therapeutics and immune-mediated skin diseaseKenneth B Gordon, Rebecca SatoskarJournal of Cutaneous Medicine and Surgery|January 26, 2005
The efficacy of alefacept in the treatment of chronic plaque psoriasisKenneth B Gordon, Jayme ValentineJournal of the American Academy of Dermatology|June 20, 2015
Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: Results of a phase III, randomized, controlled trial (Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis [ESTEEM] 1)Kim Papp, Kristian Reich, Craig L Leonardi, et al.Journal of Drugs in Dermatology : JDD|January 9, 2004
Remittive effects of intramuscular alefacept in psoriasisKenneth B Gordon, Richard G LangleySkinmed|December 16, 2003
Evolution of biologic therapies for the treatment of psoriasisKenneth B Gordon, Thomas S McCormickSeminars in Cutaneous Medicine and Surgery|July 1, 2014
Understanding therapeutic pathways and comorbidities in psoriasisKenneth B Gordon, Bruce E StroberRheumatic Diseases Clinics of North America|July 18, 2025
Combined Dermatology/Rheumatology Clinics for Management of Psoriatic Disease: Current StateEric M Ruderman, Kenneth B GordonJournal of the American Academy of Dermatology|August 2, 2003
The immunology of psoriasis and biologic immunotherapyStephanie L Mehlis, Kenneth B GordonJournal of the American Academy of Dermatology|February 21, 2006
The treatment of psoriasis and psoriatic arthritis: an interdisciplinary approachKenneth B Gordon, Eric M RudermanPageof 16